Acro Biomedical Co Ltd (ACBM)

Name: Acro Biomedical Co Ltd Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$0.0

Net Income

$42.5K

Operating Margin

N/A

Free Cash Flow

-$196K

Debt / Assets

2,844.8%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Acro Biomedical Co Ltd (ACBM).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	0	0	0	0
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	154,024	115,099	13,614	8,934
Operating Expenses	16,377	115,099	13,614	8,934
Operating Income	-16,377	-115,099	-13,614	-8,934
Interest Expense	3,129	2,710	1,948	1,367
Income Before Tax	42,526	-117,809	-15,562	-10,301
Income Tax Expense	0	0	0	0
Net Income	42,526	-117,809	-15,562	-10,301
Per Share
EPS	0.00	0.00	0.00	0.00
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Acro Biomedical Co Ltd (ACBM).
Income Statement (Annual)	2025-12-31	2024-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	0	0	658,500	1,197,500	687,964
Cost of Revenue	0	0	518,000	938,000	528,560
Gross Profit	0	0	140,500	259,500	159,404
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	154,024	37,958	5,930,237	2,667,903	289,867
Operating Expenses	154,024	37,958	16,010,237	7,953,078	289,867
Operating Income	-154,024	-37,958	-15,869,737	-7,693,578	-130,463
Interest Expense	9,154	4,339	1,706	4,250	5,082
Income Before Tax	-101,146	-42,297	-15,871,443	-7,697,828	-135,545
Income Tax Expense	0	0	-15,869,737	0	-18,092
Net Income	-101,146	-42,297	-15,871,443	-7,697,828	-117,453
Per Share
EPS	0.00	0.00	-0.26	-0.14	0.00
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Acro Biomedical Co Ltd (ACBM).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	4,098	476	5,852	95,248
Short Term Investments	0	0	0	0
Net Receivables	0	0	638,500	598,000
Inventory	0	0	12,000	0
Total Current Assets	14,098	5,076	657,537	706,415
Property Plant Equipment	0	26,898	25,719	50,432
Goodwill and Intangibles	0	0	0	0
Total Assets	14,098	31,974	687,486	761,077
Liabilities
Account Payables	55,550	154,460	76,571	26,197
Short Term Debt	325,512	53,796	25,719	24,713
Total Current Liabilities	401,062	326,946	201,116	91,651
Long Term Debt	0	0	0	25,719
Total Liabilities	401,062	326,946	201,116	117,370
Shareholders Equity
Retained Earnings	-32,758,941	-32,657,795	-23,807,925	-7,936,482
Total Shareholders Equity	-386,964	-294,972	486,370	643,707

Balance sheet annual history for Acro Biomedical Co Ltd (ACBM).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	4,098	476	5,852	95,248	18,123
Short Term Investments	0	0	0	0	0
Net Receivables	0	0	638,500	598,000	0
Inventory	0	0	12,000	0	938,000
Total Current Assets	14,098	5,076	657,537	706,415	973,353
Property Plant Equipment	0	26,898	25,719	50,432	24,700
Goodwill and Intangibles	0	0	0	0	0
Total Assets	14,098	31,974	687,486	761,077	998,053
Liabilities
Account Payables	55,550	154,460	76,571	26,197	24,734
Short Term Debt	325,512	53,796	25,719	24,713	24,500
Total Current Liabilities	401,062	326,946	201,116	91,651	312,185
Long Term Debt	0	0	0	25,719	0
Total Liabilities	401,062	326,946	201,116	117,370	312,185
Shareholders Equity
Retained Earnings	-32,758,941	-32,657,795	-23,807,925	-7,936,482	-238,654
Total Shareholders Equity	-386,964	-294,972	486,370	643,707	685,868

Cash flow quarterly history for Acro Biomedical Co Ltd (ACBM).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-101,146	-42,297	-15,871,443	-7,697,828
Depreciation & Amortization	0	0	0	0
Stock Based Compensation	0	0	15,712,400	7,651,417
Change in Working Capital	-42,278	1,266	9,856	341,296
Operating Cash Flow	-196,302	-36,692	-147,481	299,335
Investing Activities
Capital Expenditure	0	0	0	0
Investments	0	0	0	0
Investing Cash Flow	0	0	0	0
Financing Activities
Debt Repayment	199,924	36,792	-58,085	0
Common Stock Issued/Repurchased	0	0	0	0
Dividends Paid	0	0	0	0
Financing Cash Flow	199,924	36,792	58,085	-222,210
Summary
Free Cash Flow	-196,302	-36,692	-147,481	299,335
Net Change in Cash	3,622	100	-89,396	77,125

Cash flow annual history for Acro Biomedical Co Ltd (ACBM).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-101,146	-42,297	-15,871,443	-7,697,828	-117,453
Depreciation & Amortization	0	0	0	0	0
Stock Based Compensation	0	0	15,712,400	7,651,417	0
Change in Working Capital	-42,278	1,266	9,856	341,296	-89,004
Operating Cash Flow	-196,302	-36,692	-147,481	299,335	-199,460
Investing Activities
Capital Expenditure	0	0	0	0	0
Investments	0	0	0	0	0
Investing Cash Flow	0	0	0	0	0
Financing Activities
Debt Repayment	199,924	36,792	-58,085	0	0
Common Stock Issued/Repurchased	0	0	0	0	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	199,924	36,792	58,085	-222,210	216,672
Summary
Free Cash Flow	-196,302	-36,692	-147,481	299,335	-199,460
Net Change in Cash	3,622	100	-89,396	77,125	17,212